Cueing up quantum computing in biopharma

A step change in the accuracy of virtual compound screens and multiomics-optimized clinical trial recruitment are among the advances quantum computing could bring to biopharma. While large-scale deployment is years away, drug developers can start testing the waters with providers eager to co-develop high-value applications. 

Exploring use cases now could help forward-looking companies prepare for the coming quantum revolution...